AAM’S JONATHAN KIMBALL, LUPIN’S ALOK SONIG, MAYNE PHARMA’S HEM PANDYA, AND WASHINGTON UNIVERSITY’S ANTHONY SARDELLA DISCUSS WHAT WENT RIGHT WITH THE GENERIC INDUSTRY’S COVID RESPONSE. • Source: Nielsen Hobbs
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
